➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Johnson and Johnson
McKinsey
Moodys
Express Scripts

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208843


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 208843 describes SIKLOS, which is a drug marketed by Addmedica Sas and is included in one NDA. Additional details are available on the SIKLOS profile page.

The generic ingredient in SIKLOS is hydroxyurea. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
Summary for 208843
Tradename:SIKLOS
Applicant:Addmedica Sas
Ingredient:hydroxyurea
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Dec 21, 2017TE:RLD:Yes
Regulatory Exclusivity Expiration:Dec 21, 2020
Regulatory Exclusivity Use:NEW PRODUCT
Regulatory Exclusivity Expiration:Dec 21, 2024
Regulatory Exclusivity Use:TO REDUCE THE FREQUENCY OF PAINFUL CRISES AND TO REDUCE THE NEED FOR BLOOD TRANSFUSIONS IN PEDIATRIC PATIENTS, 2 YEARS OF AGE AND OLDER, WITH SICKLE CELL ANEMIA WITH RECURRENT MODERATE TO SEVERE PAINFUL CRISIS

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1GM
Approval Date:Dec 21, 2017TE:RLD:Yes
Regulatory Exclusivity Expiration:Dec 21, 2020
Regulatory Exclusivity Use:NEW PRODUCT

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Harvard Business School
Mallinckrodt
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.